Table 2.
Quality assessment and risk of bias of included case series (IHE).
| Study | Study objective | Study design | Study population | Intervention and co-intervention | Outcome measures | Statistical analysis | Results and conclusions | Competing interests and sources of support | Total |
|---|---|---|---|---|---|---|---|---|---|
| Konersman CG2021 | 1/1 | 1/3 | 3/3 | 2/2 | 3/4 | 1/1 | 4/5 | 1/1 | 16/20 |
| De Vivo DC2019 | 1/1 | 1/3 | 3/3 | 2/2 | 3/4 | 1/1 | 4/5 | 1/1 | 16/20 |
| Szabó L2020 | 1/1 | 2/3 | 3/3 | 2/2 | 3/4 | 1/1 | 4/5 | 1/1 | 17/20 |
| Pechmann A2018 | 1/1 | 2/3 | 3/3 | 2/2 | 3/4 | 1/1 | 4/5 | 1/1 | 17/20 |
| Audic F2020 | 1/1 | 2/3 | 3/3 | 2/2 | 3/4 | 1/1 | 4/5 | 1/1 | 17/20 |
| Chiriboga CA2016 | 1/1 | 2/3 | 3/3 | 2/2 | 3/4 | 1/1 | 4/5 | 1/1 | 17/20 |
| Osredkar D2021 | 1/1 | 1/3 | 3/3 | 2/2 | 2/4 | 1/1 | 4/5 | 1/1 | 15/20 |
| Finkel RS2021 | 1/1 | 1/3 | 3/3 | 2/2 | 2/4 | 1/1 | 4/5 | 1/1 | 15/20 |
| Haché M2016 | 1/1 | 1/3 | 3/3 | 2/2 | 2/4 | 1/1 | 3/5 | 1/1 | 14/20 |
| Sansone VA2019 | 1/1 | 1/3 | 3/3 | 2/2 | 2/4 | 1/1 | 4/5 | 1/1 | 15/20 |
| Wataya T2021 | 1/1 | 1/3 | 2/3 | 2/2 | 2/4 | 1/1 | 4/5 | 1/1 | 14/20 |